Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 1, 2004
Development of required postgraduate palliative care training for internal medicine residents and medical oncology fellowsDouglas D Ross, Deborah Shpritz, Carla S Alexander, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003)Suresh S Ramalingam, Angela M Davies, Jeffrey Longmate, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Chest|February 4, 2009
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera, Frank C Detterbeck, Mark A Socinski, et al.
JTO Clinical and Research Reports|December 2, 2024
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S Tsao, Ming-Hui Hsieh, Marianna Koczywas, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 1, 2004
Development of required postgraduate palliative care training for internal medicine residents and medical oncology fellowsDouglas D Ross, Deborah Shpritz, Carla S Alexander, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003)Suresh S Ramalingam, Angela M Davies, Jeffrey Longmate, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)Martin J Edelman, Mary W Redman, Kathy S Albain, et al.
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
Cancer Letters|September 5, 2025
Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in BloodDaniel L Adams, Massimo Cristofanilli, Steven H Lin, et al.
Clinical Lung Cancer|November 12, 2019
Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative IntentStephanie R Rice, Melissa A L Vyfhuis, Katherine A Scilla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101Antonius A Miller, Daryl J Murry, Kouros Owzar, et al.
JCO Oncology Practice|September 30, 2020
Benchmarks for Academic Oncology FacultyLowell Anthony, George Atweh, Ravi Bhatia, et al.
Pageof 19